Barchart.com
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Menu
alerts false
Stocks | Futures | Watchlist | News | More
 
Advanced search
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Altimmune Inc (ALT)

Altimmune Inc (ALT)
5.03 x 1 5.14 x 2
Post-market by (Cboe BZX)
5.07 -0.10 (-1.93%) 04/25/25 [NASDAQ]
5.03 x 1 5.14 x 2
Post-market 5.10 +0.03 (+0.59%) 18:56 ET
News & Headlines for Fri, Apr 25th, 2025
Notes
Alerts
Watch
    Add or delete the symbol from one or more Watchlists.
  • Create New Watchlist
    This name already in use.
Help
Go To:
Buying These Dirt-Cheap Stocks Could Be a Brilliant Move Motley Fool - Sat Mar 22, 5:44AM CDT

Valuation always matters in investing. And sometimes you can find stocks that are especially great bargains.

ALT : 5.07 (-1.93%)
MRNA : 27.22 (-0.62%)
PFE : 22.92 (+0.61%)
Altimmune Shares Sink This Year, But Retail Traders See A Buyout On The Horizon Stocktwits - Wed Mar 19, 12:56AM CDT

A Betaville report suggested Altimmune has begun a strategic review with an adviser, with speculation that three major pharmaceutical firms may be involved.

ALT : 5.07 (-1.93%)
VTI : 270.64 (+0.61%)
IWM : 194.12 (+0.03%)
XBI : 80.25 (-0.79%)
Altimmune to Host Virtual R&D Day on March 13, 2025 GlobeNewswire - Thu Mar 6, 6:30AM CST

ALT : 5.07 (-1.93%)
Altimmune to Participate in the Leerink Global Healthcare Conference GlobeNewswire - Mon Mar 3, 6:30AM CST

ALT : 5.07 (-1.93%)
Altimmune Retail Buzz Heats Up On MASH Progress, FDA Nod For New Trials: Stock Jumps After Q4 Print Stocktwits - Thu Feb 27, 9:48PM CST

The company plans to unveil details at its virtual R&D Day on March 13.

ALT : 5.07 (-1.93%)
VTI : 270.64 (+0.61%)
IWM : 194.12 (+0.03%)
XBI : 80.25 (-0.79%)
Altimmune Announces Fourth Quarter and Full Year 2024 Financial Results and Provides a Business Update GlobeNewswire - Thu Feb 27, 6:00AM CST

ALT : 5.07 (-1.93%)
Seasoned Biopharmaceutical Industry Executives Teri Lawver and Jerry Durso Appointed to Altimmune Board of Directors GlobeNewswire - Tue Feb 25, 6:30AM CST

ALT : 5.07 (-1.93%)
Altimmune to Report Fourth Quarter and Full Year 2024 Financial Results and Provide Business Update on February 27, 2025 GlobeNewswire - Thu Feb 20, 6:30AM CST

ALT : 5.07 (-1.93%)
Altimmune to Participate in the Guggenheim SMID Cap Biotech Conference GlobeNewswire - Wed Jan 29, 6:30AM CST

ALT : 5.07 (-1.93%)
Why Altimmune Was Such a Robustly Healthy Stock on Thursday Motley Fool - Thu Dec 19, 2024

Altimmune (NASDAQ: ALT) had some encouraging news to share with the world as the trading week drew near a close on Thursday. The biotech announced that it will soon ascend to an important, specialized...

ALT : 5.07 (-1.93%)

Barchart Exclusives

2 ‘Strong Buy’ Stocks to Buy on Plans to Increase American Manufacturing Barchart - 35 minutes ago
Two checkered names from diverse industries are looking to bolster their manufacturing capabilities in the U.S. Here's how they stack up as investment ideas. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Value Investing Philosophies: Graham, Buffett, Bogle, and EMH in Perspective
Wed, Apr 30, 2025 5:00 PM UTC
Reserve Your Spot